Form 4 for OGN Organon & Co.
Accepted 2025-02-24 00:00:00 ET · period of report 2025-02-20 · accession 0001821825-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-24 | 2025-02-20 | OGN | WALSH MATTHEW M | CFO | F - Tax | $14.98 | -12.6K | 111.7K | -10% | -$188.3K |
| M | 2025-02-24 | 2025-02-20 | OGN | WALSH MATTHEW M | CFO | A - Grant | $0.00 | +36.0K | 122.4K | +42% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-20 | F | D | 1,908 | $15.29 | 115,388 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-20 | A | A | 5,570 | $0.00 | 117,296 | D | — | — | (F2) Represents the shares of Common Stock released to cover the dividend equivalents earned on the PSUs released above. |
| 3 | Common | Common Stock | 2025-02-20 | F | D | 10,662 | $14.92 | 111,726 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-20 | A | A | 30,414 | $0.00 | 122,388 | D | — | — | (F1) Represents shares of Organon & Co. common stock ("Common Stock") for performance share units ("PSUs") granted to the reporting person on August 09, 2022 under the Organon & Co. 2021 Incentive Stock Plan. The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of Directors. |